You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 31 No. 4, October 1974 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Multiple Forms of Brain Monoamine Oxidase in Schizophrenic and Normal Individuals

Michael A. Schwartz, MD; Richard J. Wyatt, MD; Hsiu-Ying T. Yang, PhD; Norton H. Neff, PhD

Arch Gen Psychiatry. 1974;31(4):557-560.


Abstract

Two forms of monoamine oxidase were identified in 15 regions of the brain. These enzymes were ientified by their sensitivity to the drugs clorgyline and N-(1-phenylisopropyl)-N-methyl-N-propionylamine (E 250 or Deprenyl, Hungary) and by their ability to deaminate serotonin and β-phenylethylamine. Enzyme activity was rather uniformly distributed in the brain. There were no statistically significant differences of enzyme activity when compared in three regions of the brain from mentally normal and chronic schizophrenic subjects. There were, however, large variations of enzyme activities within the groups of subjects tested that could have masked true differences of enzyme activity.



Author Affiliations

From the Laboratory of Clinical Psychopharmacology (Drs. Schwartz and Wyatt) and Laboratory of Preclinical Pharmacology (Drs. Yang and Neff), National Institute of Mental Health, St. Elizabeths Hospital, Washington, DC. Dr. Schwartz is now with the New York Hospital-Cornell Medical Center, Westchester Division, White Plains, NY.


Footnotes

Accepted for publication May 21, 1974.

Reprint requests to the Laboratory of Clinical Psychopharmacology, National Institute of Mental Health, St. Elizabeths Hospital, WAW Building, Washington, DC 20032 (Dr. Schwartz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human Monoamine Oxidase: Lack of Brain and Platelet Correlation
Young et al.
Arch Gen Psychiatry 1986;43:604-609.
ABSTRACT  

Brain Monoamine Oxidase Activity in Schizophrenics and Controls
Reveley et al.
Arch Gen Psychiatry 1981;38:663-665.
ABSTRACT  

Skeletal Muscle MAO Activity in the Major Psychoses: Relationship With Platelet and Plasma MAO Activities
Meltzer and Arora
Arch Gen Psychiatry 1980;37:333-339.
ABSTRACT  

Decreased Platelet Monoamine Oxidase Activity in Chronic Schizophrenia, Shown With Novel Substrates
Berrettini et al.
Arch Gen Psychiatry 1978;35:600-605.
ABSTRACT  

Possible Changes in Striatal and Limbic Cholinergic Systems in Schizophrenia
McGeer and McGeer
Arch Gen Psychiatry 1977;34:1319-1323.
ABSTRACT  

The Human Platelet: A Diagnostic and Research Tool for the Study of Biogenic Amines in Psychiatric and Neurologic Disorders
Stahl
Arch Gen Psychiatry 1977;34:509-516.
ABSTRACT  

Platelet Monamine Oxidase in Schizophrenia: An Investigation in Drug-Free Chronic Hospitalized Patients
Owen et al.
Arch Gen Psychiatry 1976;33:1370-1373.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.